Global Electroencephalography Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Electroencephalography Devices Market Size

• The global electroencephalography devices market size was valued at USD 1.30 billion in 2024 and is expected to reach USD 1.97 billion by 2032, at a CAGR of 5.40% during the forecast period
• This growth is driven by factors such as the increasing prevalence of neurological disorders, advancements in EEG technology, integration of artificial intelligence (AI), expansion of research applications, and rising demand for non-invasive and portable devices

Electroencephalography Devices Market Analysis

• An electroencephalogram refers to a test that makes the use of small metal discs (electrodes) connected to the scalp for detecting activity in the brain. The increase in the prevalence of neurological disorders is escalating the growth of electroencephalography devices market
• Electroencephalography equipment refers to the equipment that is utilized for monitoring the electrical signals of the brain. The readings from these devices are used for diagnosing neurological disorders and monitoring neurological disorders, and sleep disorders
• North America is expected to dominate the electroencephalography devices market with 36% due Increasing occurrences of sleep and neurodegenerative conditions, along with improved insurance coverage, are critical drivers of regional expansion
• Asia-Pacific is expected to be the fastest growing region in the electroencephalography devices market during the forecast period due to region's substantial population, increasing healthcare expenditure, and increasing demand for advanced medical treatments and technologies
• 32 channel EEG is expected to dominate the market with a market share of 28.1% due to the device’s enhanced diagnostic capabilities and higher spatial resolution. As healthcare providers seek more comprehensive insights into brain activity, the demand for EEG systems with increased channel capacity is rising

Report Scope and Electroencephalography Devices Market Segmentation         

Electroencephalography Devices Market Trends

“Growth in Research Applications”

• EEG devices are increasingly utilized in cognitive neuroscience, psychology research, and neuromarketing, expanding their application beyond clinical settings
• EEG devices are pivotal in cognitive neuroscience and psychology, facilitating the study of brain activities associated with perception, attention, memory, and decision-making
• Researchers employ EEG to investigate neural correlates of cognitive processes, providing insights into how the brain processes information 
  • For instance, studies have utilized EEG to explore the neural mechanisms underlying attention and working memory, enhancing our understanding of these cognitive functions 
• In neuromarketing, EEG technology is employed to assess consumer responses to advertisements, products, and branding. By analyzing brainwave patterns, companies can gauge emotional reactions and cognitive engagement, informing marketing strategies

Electroencephalography Devices Market Dynamics

Driver

“Increasing Incidence of Neurological Disorders”

• The escalating prevalence of neurological disorders is a primary driver of the EEG devices market
• Conditions such as epilepsy, Alzheimer's disease, and sleep disorders are becoming more common globally, necessitating advanced diagnostic tools 
  • For instance, the World Health Organization reports that over 50 million people worldwide are affected by epilepsy  
• These statistics underscore the growing need for effective diagnostic solutions, propelling the demand for EEG devices

Opportunity

“Expansion of Telemedicine and Remote Monitoring”

• The rise of telemedicine presents a significant opportunity for the EEG devices market
• The COVID-19 pandemic accelerated the adoption of remote healthcare services, highlighting the need for portable and user-friendly diagnostic tools
• EEG devices equipped with wireless connectivity and real-time data transmission capabilities are well-suited for remote monitoring of neurological conditions
• This shift enables continuous patient monitoring, timely interventions, and improved patient outcomes, particularly in underserved or rural areas where access to healthcare facilities may be limited

Restraint/Challenge

“High Cost and Accessibility Issues”

• Despite their benefits, the high cost of advanced EEG devices poses a significant challenge to their widespread adoption
• The initial purchase price, coupled with maintenance, software upgrades, and training costs, can be prohibitive, especially for healthcare providers in developing regions
• Additionally, the complexity of EEG data interpretation requires specialized training, and the shortage of skilled personnel can hinder the effective use of EEG devices
• These factors contribute to accessibility issues, limiting the reach of EEG technology to a broader patient population

Electroencephalography Devices Market Scope

The market is segmented on the basis of product type, type, usability, procedure, function, signal frequency, filtering settings, age group, application, end user, and distribution channel

In 2025, the 32 channel EEG is projected to dominate the market with a largest share in procedure segment

The 32 channel EEG is expected to dominate the Electroencephalography Devices market with the largest share of 28.1% in 2025 due to the device’s enhanced diagnostic capabilities and higher spatial resolution. As healthcare providers seek more comprehensive insights into brain activity, the demand for EEG systems with increased channel capacity is rising. The 32-channel configuration allows simultaneous monitoring of multiple brain regions, enabling more accurate assessments of cognitive function and neurological disorders

The standalone is expected to account for the largest share during the forecast period in type market

In 2025, the standalone segment is expected to dominate the market with the largest market share of 32.4% due to EEG devices play a crucial role in diagnosing various neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. The rising prevalence of these conditions and the growing awareness about the importance of early diagnosis are likely to drive the demand for EEG devices for disease diagnosis.

Electroencephalography Devices Market Regional Analysis

“North America Holds the Largest Share in the Electroencephalography Devices Market”

• North America led the global EEG devices market with 36% of the global share
• U.S. dominate the global electroencephalography devices market. This dominance is attributed to its regulatory environments and reimbursement policies have facilitated the introduction and widespread use of EEG devices in clinical settings
• The region boasts cutting-edge healthcare infrastructure and a high adoption rate of advanced medical technologies, including 32-channel and multichannel EEG systems
• Significant investments in R&D by key players such as Medtronic and Natus Medical have fostered innovation and product development
• Favorable regulatory environments and reimbursement policies have facilitated the introduction and widespread use of EEG devices in clinical settings

“Asia-Pacific is Projected to Register the Highest CAGR in the Electroencephalography Devices Market”

• China, India, and Japan are leading the growth, driven by increasing healthcare investments and a rising elderly population
• 32-channel EEG systems were the largest revenue-generating product , with multichannel EEG systems registering the fastest growth during the forecast period
• Ongoing improvements in healthcare infrastructure and accessibility are contributing to the market expansion
• The region's growth is further supported by increasing prevalence of neurological disorders and a shift towards non-invasive diagnostic methods

Electroencephalography Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Cadwell Industries Inc. (U.S.)
• Compumedics Limited (Australia)
• NeuroWave Systems Inc. (U.S.)
• Natus Medical Incorporated(U.S.)
• Medtronic (Ireland)
• NIHON KOHDEN CORPORATION (Japan)
• NeuroSky (China)
• Bio-Signal Group Corp. (U.S.)
• Elekta AB (Sweden)
• Lifelines Neuro (U.S.)
• Neurosoft S.A. (Greece)
• EMS Handels Gesellschaft mbH (Austria)
• Jordan NeuroScience, Inc. (U.S.)
• BrainScope Company Inc. (U.S.)
• Advanced Brain Monitoring, Inc. (U.S.)
• EB Neuro S.p.A. (Italy)
• g.tec medical engineering GmbH Austria (Austria)
• Bitbrain Technologies (Spain)
• Electrical Geodesics, Inc. (U.S.)
• Masimo (U.S.)
• ELMIKO MEDICAL sp. Z oo (Poland)
• Micromed (Italy)

Latest Developments in Global Electroencephalography Devices Market

• In March 2025, PiEEG Box is a multifunctional, compact, and mobile device that allows for the measurement of EEG, EMG, EOG, and EKG signals. It incorporates a Raspberry Pi-based EEG shield, an EEG electrode cap, a display screen, additional sensors for body parameters, and other necessary peripherals into a single, portable unit
• In October 2024, Neurable introduced the MW75 Neuro, a pair of active noise-cancelling wireless headphones equipped with EEG sensors to monitor brain activity and assess focus levels.
•  In February 2024, Neurotechnology's enhanced BrainAccess EEG solutions showcased upgraded headwear, expanded software functionalities, and the introduction of a novel 32-channel system
• In January 2024, Gate entered into a collaboration with Beacon to employ EEG biomarkers in its Phase II trial for Major Depressive Disorder (MDD). The trial is expected to utilize Beacon's Dreem 3S headband device for exploratory EEG and sleep analyses in participants. Scheduled to commence in mid-2024, the Phase II investigation of Gate's zelquistine aims to advance understanding and potential treatments for MDD.
• In January 2024, Aditxt, a biotechnology company headquartered in the U.S., collected EEG brain monitoring technologies and devices from Brain Scientific. The acquisition comprised a portfolio of 16 patents, which includes a disposable NeuroCap and a portable NeuroEEG.
• In July 2023, a significant USD 1.5 million funding boost to the universities of Bath and Bristol was expected to help patients and & families with an easy-to-use Fastball EEG test to improve the early detection of dementia and Alzheimer's disease.      

SKU-1407